<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=9808320" created="16/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>9808320</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="YM268" sem="Organic_compound_other">YM268</term> increases the <term id="T2" lex="glucose_uptake" sem="Other"><term id="A1" sem="Carbohydrate">glucose</term> uptake</term>, cell differentiation, and <term id="T3" lex="mRNA_expression" sem="Other">mRNA expression</term> of <term id="T4" lex="glucose_transporter" sem="Protein_complex">glucose transporter</term> in <term id="T5" lex="3T3-L1_adipocyte" sem="Cell_natural">3T3-L1 adipocytes</term>.</sentence>
<event id="E1">
<type class="Localization"/>
<theme idref="A1"/>
<clue>YM268 increases the glucose <clueType>uptake</clueType>, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.</clue>
</event>
<event id="E2">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="T1"/>
<clue>YM268 <clueType>increases</clueType> the glucose uptake, cell differentiation, and mRNA expression of glucose transporter <clueLoc>in 3T3-L1 adipocytes</clueLoc>.</clue>
</event>
<event id="E3">
<type class="Cell_differentiation"/>
<theme idref="T5"/>
<clue>YM268 increases the glucose uptake, <clueType>cell differentiation</clueType>, and mRNA expression of glucose transporter <linkTheme>in</linkTheme> 3T3-L1 adipocytes.</clue>
</event>
<event id="E4">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T1"/>
<clue>YM268 <clueType>increases</clueType> the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes.</clue>
</event>
<event id="E5">
<type class="Transcription"/>
<theme idref="T4"/>
<clue>YM268 increases the glucose uptake, cell differentiation, and <clueType>mRNA expression</clueType> <linkTheme>of</linkTheme> glucose transporter in 3T3-L1 adipocytes.</clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="E5"/>
<cause idref="T1"/>
<clue>YM268 <clueType>increases</clueType> the glucose uptake, cell differentiation, and mRNA expression of glucose transporter <clueLoc>in 3T3-L1 adipocytes</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The purpose of this study was to examine the effects of <term id="T6" lex="bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane" sem="Organic_compound_other">bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane</term> (<term id="T7" lex="YM-268" sem="Organic_compound_other">YM-268</term>), a <term id="T8" lex="thiazolidinedione_derivative" sem="Organic_compound_other">thiazolidinedione derivative</term>, on <term id="T9" lex="glucose_uptake" sem="Other"><term id="A2" sem="Carbohydrate">glucose</term> uptake</term>, <term id="T10" lex="adipocyte_differentiation" sem="Other"><term id="T11" lex="adipocyte" sem="Cell_natural">adipocyte</term> differentiation</term> through <term id="T12" lex="peroxisome_proliferator-activated_receptor_gamma" sem="Protein_molecule">peroxisome proliferator-activated receptor gamma</term>(<term id="T13" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term>), and <term id="T14" lex="phosphatidylinositol_3-kinase_(PI_3-kinase)_activity" sem="Other"><term id="T15" lex="phosphatidylinositol_3-kinase" sem="Protein_molecule">phosphatidylinositol 3-kinase</term> (<term id="T16" lex="PI_3-kinase" sem="Protein_molecule">PI 3-kinase</term>) activity</term> in <term id="T17" lex="cultured_cell" sem="Cell_cultured">cultured cells</term>.</sentence>
<event KT="Other" id="E7">
<type class="Localization"/>
<theme idref="A2"/>
<clue>The purpose of this study was to examine the effects of bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose <clueType>uptake</clueType>, adipocyte differentiation through peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity in cultured cells.</clue>
</event>
<event KT="Other" id="E8">
<type class="Cell_differentiation"/>
<theme idref="A2"/>
<clue>The purpose of this study was to examine the effects of bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose uptake, adipocyte <clueType>differentiation</clueType> through peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity in cultured cells.</clue>
</event>
<event KT="Other" id="E101">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T13"/>
<clue>The purpose of this study was to examine the effects of bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose uptake, adipocyte differentiation <linkCause>through</linkCause> peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity in cultured cells.</clue>
</event>
<event KT="Investigation" id="E102">
<type class="Regulation"/>
<theme idref="E7"/>
<cause idref="T7"/>
<clue>The purpose of this study was <clueKT>to examine</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose uptake, adipocyte differentiation through peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity <clueLoc>in cultured cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E9">
<type class="Regulation"/>
<theme idref="E101"/>
<cause idref="T7"/>
<clue>The purpose of this study was <clueKT>to examine</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose uptake, adipocyte differentiation through peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity <clueLoc>in cultured cells</clueLoc>.</clue>
</event>
<event KT="Investigation" id="E10">
<type class="Regulation"/>
<theme idref="T16"/>
<cause idref="T7"/>
<clue>The purpose of this study was <clueKT>to examine</clueKT> the <clueType>effects</clueType> <linkCause>of</linkCause> bis[4-[2,4-dioxo-5-thiazolidinyl)methyl]phenyl]methane (YM-268), a thiazolidinedione derivative, on glucose uptake, adipocyte differentiation through peroxisome proliferator-activated receptor gamma(PPARgamma), and phosphatidylinositol 3-kinase (PI 3-kinase) activity <clueLoc>in cultured cells</clueLoc>.</clue>
</event>
<sentence id="S3"><term id="T18" lex="YM268" sem="Organic_compound_other">YM268</term> and <term id="T19" lex="pioglitazone" sem="Organic_compound_other">pioglitazone</term> dose-dependently increased the <term id="T20" lex="2-deoxyglucose_uptake" sem="Other"><term id="T21" lex="2-deoxyglucose" sem="Carbohydrate">2-deoxyglucose</term> uptake</term> in <term id="T22" lex="3T3-L1_cell" sem="Cell_cultured">3T3-L1 cells</term>.</sentence>
<event id="E11">
<type class="Localization"/>
<theme idref="T21"/>
<clue>YM268 and pioglitazone dose-dependently increased the 2-deoxyglucose <clueType>uptake</clueType> in 3T3-L1 cells.</clue>
</event>
<event id="E12">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="T18"/>
<clue>YM268 and pioglitazone dose-dependently <clueType>increased</clueType> the 2-deoxyglucose uptake <clueLoc>in 3T3-L1 cells</clueLoc>.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="T19"/>
<clue>YM268 and pioglitazone dose-dependently <clueType>increased</clueType> the 2-deoxyglucose uptake <clueLoc>in 3T3-L1 cells</clueLoc>.</clue>
</event>
<sentence id="S4"><term id="T23" lex="YM268" sem="Organic_compound_other">YM268</term> facilitated the <term id="T24" lex="insulin-stimulated_triglyceride_accumulation" sem="Other"><term id="A3" sem="Protein_molecule">insulin</term>-stimulated <term id="A4" sem="Lipid">triglyceride</term> accumulation</term> in <term id="T25" lex="3T3-L1_adipocyte" sem="Cell_natural">3T3-L1 adipocytes</term> and increased the <term id="T26" lex="mRNA_expression" sem="Other">mRNA expression</term> of <term id="T27" lex="fatty_acid-binding_protein" sem="Protein_molecule">fatty acid-binding protein</term>.</sentence>
<event id="E14">
<type class="Metabolism"/>
<theme idref="A4"/>
<clue>YM268 facilitated the insulin-stimulated triglyceride <clueType>accumulation</clueType> in 3T3-L1 adipocytes and increased the mRNA expression of fatty acid-binding protein.</clue>
</event>
<event id="E15">
<type class="Positive_regulation"/>
<theme idref="E14"/>
<cause idref="A3"/>
<clue>YM268 facilitated the insulin-<clueType>stimulated</clueType> triglyceride accumulation in 3T3-L1 adipocytes and increased the mRNA expression of fatty acid-binding protein.</clue>
</event>
<event id="E16">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="T23"/>
<clue>YM268 <clueType>facilitated</clueType> the insulin-stimulated triglyceride accumulation <clueLoc>in 3T3-L1 adipocytes</clueLoc> and increased the mRNA expression of fatty acid-binding protein.</clue>
</event>
<event id="E17">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>YM268 facilitated the insulin-stimulated triglyceride accumulation in 3T3-L1 adipocytes and increased the <clueType>mRNA expression</clueType> <linkTheme>of</linkTheme> fatty acid-binding protein.</clue>
</event>
<event id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T23"/>
<clue>YM268 facilitated the insulin-stimulated triglyceride accumulation in 3T3-L1 adipocytes and <clueType>increased</clueType> the mRNA expression of fatty acid-binding protein.</clue>
</event>
<sentence id="S5"><term id="T28" lex="YM268" sem="Organic_compound_other">YM268</term>, with and without <term id="T29" lex="insulin" sem="Peptide">insulin</term>, increased the <term id="T30" lex="mRNA_expression" sem="Other">mRNA expression</term> of <term id="T31" lex="glucose_transporter" sem="Protein_complex">glucose transporter</term> isoforms such as <term id="T32" lex="GLUT1" sem="Protein_complex">GLUT1</term> and <term id="T33" lex="GLUT4" sem="Protein_complex">GLUT4</term>, indicating enhancement of <term id="T34" lex="adipocyte_differentiation" sem="Other"><term id="T35" lex="adipocyte" sem="Cell_natural">adipocyte</term> differentiation</term>.</sentence>
<event id="E19">
<type class="Transcription"/>
<theme idref="T31"/>
<clue>YM268, with and without insulin, increased the <clueType>mRNA expression</clueType> <linkTheme>of</linkTheme> glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E20">
<type class="Transcription"/>
<theme idref="T32"/>
<clue>YM268, with and without insulin, increased the <clueType>mRNA expression</clueType> <linkTheme>of</linkTheme> <corefTheme>glucose transporter isoforms</corefTheme> such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E21">
<type class="Transcription"/>
<theme idref="T33"/>
<clue>YM268, with and without insulin, increased the <clueType>mRNA expression</clueType> <linkTheme>of</linkTheme> <corefTheme>glucose transporter isoforms</corefTheme> such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E22">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T28"/>
<clue>YM268, with and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E23">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T28"/>
<clue>YM268, with and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E24">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T28"/>
<clue>YM268, with and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E25">
<type class="Positive_regulation"/>
<theme idref="E19"/>
<cause idref="T28"/>
<cause idref="T29"/>
<clue>YM268, <linkCause>with</linkCause> and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E26">
<type class="Positive_regulation"/>
<theme idref="E20"/>
<cause idref="T28"/>
<cause idref="T29"/>
<clue>YM268, <linkCause>with</linkCause> and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event id="E27">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="T28"/>
<cause idref="T29"/>
<clue>YM268, <linkCause>with</linkCause> and without insulin, <clueType>increased</clueType> the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte differentiation.</clue>
</event>
<event KT="Other" id="E28">
<type class="Cell_differentiation"/>
<theme idref="T35"/>
<clue>YM268, with and without insulin, increased the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, indicating enhancement of adipocyte <clueType>differentiation</clueType>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E29">
<type class="Positive_regulation"/>
<theme idref="E28"/>
<clue>YM268, with and without insulin, increased the mRNA expression of glucose transporter isoforms such as GLUT1 and GLUT4, <clueKT><clueCL>indicating</clueCL></clueKT> <clueType>enhancement</clueType> <linkTheme>of</linkTheme> adipocyte differentiation.</clue>
</event>
<sentence id="S6">Additionally, <term id="T36" lex="YM268" sem="Organic_compound_other">YM268</term> and <term id="T37" lex="pioglitazone" sem="Organic_compound_other">pioglitazone</term> showed activity of the <term id="T38" lex="PPARgamma_ligand" sem="Protein_molecule"><term id="T39" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> ligand</term>, a member of the <term id="T40" lex="nuclear_receptor_superfamily" sem="Protein_family_or_group">nuclear receptor superfamily</term> responsible for <term id="T41" lex="adipogenesis" sem="Other">adipogenesis</term>.</sentence>
<event KT="Analysis" id="E30">
<type class="Binding"/>
<theme idref="T36"/>
<theme idref="T39"/>
<clue>Additionally, YM268 and pioglitazone <clueType><clueKT>showed</clueKT> activity of</clueType> the PPARgamma <clueType>ligand</clueType>, a member of the nuclear receptor superfamily responsible for adipogenesis.</clue>
</event>
<event KT="Analysis" id="E31">
<type class="Binding"/>
<theme idref="T37"/>
<theme idref="T39"/>
<clue>Additionally, YM268 and pioglitazone <clueType><clueKT>showed</clueKT> activity of</clueType> the PPARgamma <clueType>ligand</clueType>, a member of the nuclear receptor superfamily responsible for adipogenesis.</clue>
</event>
<event KT="Fact" id="E32">
<type class="Positive_regulation"/>
<theme idref="T41"/>
<cause idref="T39"/>
<clue>Additionally, YM268 and pioglitazone showed activity of the PPARgamma ligand, <corefTheme>a member of the nuclear receptor superfamily</corefTheme> <clueType>responsible</clueType> <linkTheme>for</linkTheme> adipogenesis.</clue>
</event>
<sentence id="S7">To examine the possible involvement of the increased activity of <term id="T42" lex="PI_3-kinase" sem="Protein_molecule">PI 3-kinase</term> in <term id="T43" lex="YM268" sem="Organic_compound_other">YM268</term>-stimulated <term id="T44" lex="glucose_uptake" sem="Other"><term id="A5" sem="Carbohydrate">glucose</term> uptake</term>, the <term id="T45" lex="enzyme_activity" sem="Other">enzyme activity</term> was estimated by measuring the <term id="T46" lex="phosphatidylinositol-3,4,5-trisphosphate" sem="Organic_compound_other">phosphatidylinositol-3,4,5-trisphosphate</term> (<term id="T47" lex="PI-3,4,5-P3" sem="Organic_compound_other">PI-3,4,5-P3</term>) concentration in <term id="T48" lex="human_monocytic_cell" sem="Cell_natural">human monocytic cells</term>.</sentence>
<event KT="Other" id="E33">
<type class="Localization"/>
<theme idref="A5"/>
<clue>To examine the possible involvement of the increased activity of PI 3-kinase in YM268-stimulated glucose <clueType>uptake</clueType>, the enzyme activity was estimated by measuring the phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) concentration in human monocytic cells.</clue>
</event>
<event KT="Other" id="E34">
<type class="Positive_regulation"/>
<theme idref="E33"/>
<cause idref="T43"/>
<clue>To examine the possible involvement of the increased activity of PI 3-kinase in YM268-<clueType>stimulated</clueType> glucose uptake, the enzyme activity was estimated by measuring the phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) concentration in human monocytic cells.</clue>
</event>
<event KT="Other" id="E35">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<clue>To examine the possible involvement of the <clueType>increased activity</clueType> <linkTheme>of</linkTheme> PI 3-kinase in YM268-stimulated glucose uptake, the enzyme activity was estimated by measuring the phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) concentration in human monocytic cells.</clue>
</event>
<event KT="Investigation" id="E36" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="E35"/>
<theme idref="E34"/>
<clue><clueKT>To examine</clueKT> the possible <clueType>involvement</clueType> <linkTheme>of</linkTheme> the increased activity of PI 3-kinase <linkTheme>in</linkTheme> YM268-stimulated glucose uptake, the enzyme activity was estimated by measuring the phosphatidylinositol-3,4,5-trisphosphate (PI-3,4,5-P3) concentration in human monocytic cells.</clue>
</event>
<sentence id="S8"><term id="A6" sem="Protein_molecule">Insulin</term> dose-dependently increased the <term id="T49" lex="PI-3,4,5-P3_production" sem="Other"><term id="T50" lex="PI-3,4,5-P3" sem="Organic_compound_other">PI-3,4,5-P3</term> production</term> but <term id="T51" lex="YM268" sem="Organic_compound_other">YM268</term> had no significant effect on the <cons id="T52" lex="(AND insulin-dependent_PI_3-kinase_activation insulin-independent_PI_3-kinase_activation)" sem="(AND Other Other)"><frag id="F1"><term id="A7" sem="Protein_molecule">insulin</term></frag><frag id="F2">-dependent</frag> and <frag id="F3">-independent</frag> <frag id="F4"><term id="A8" sem="Protein_molecule">PI 3-kinase</term> activation</frag></cons>.</sentence>
<event id="E37">
<type class="Metabolism"/>
<theme idref="T50"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 <clueType>production</clueType> but YM268 had no significant effect on the insulin-dependent and -independent PI 3-kinase activation.</clue>
</event>
<event id="E38">
<type class="Positive_regulation"/>
<theme idref="E37"/>
<cause idref="A6"/>
<clue>Insulin dose-dependently <clueType>increased</clueType> the PI-3,4,5-P3 production but YM268 had no significant effect on the insulin-dependent and -independent PI 3-kinase activation.</clue>
</event>
<event id="E39">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<cause idref="A7"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 production but YM268 had no significant effect on the insulin-<linkCause>dependent</linkCause> and -independent PI 3-kinase <clueType>activation</clueType>.</clue>
</event>
<event id="E40">
<type class="Positive_regulation"/>
<theme idref="A8"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 production but YM268 had no significant effect on the insulin-dependent and -independent PI 3-kinase <clueType>activation</clueType>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E41">
<type class="Correlation"/>
<theme idref="E40"/>
<theme idref="A7"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 production but YM268 had no significant effect on the insulin-dependent and -<clueType><cluePolarity>independent</cluePolarity></clueType> PI 3-kinase activation.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E42">
<type class="Regulation"/>
<theme idref="E39"/>
<cause idref="T51"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 production but YM268 <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueManner>significant</clueManner> <clueType>effect</clueType> <linkTheme>on</linkTheme> the insulin-dependent and -independent PI 3-kinase activation.</clue>
</event>
<event Manner="High" Polarity="Negative" assertion="non-exist" id="E43">
<type class="Regulation"/>
<theme idref="E40"/>
<cause idref="T51"/>
<clue>Insulin dose-dependently increased the PI-3,4,5-P3 production but YM268 <clueType>had</clueType> <cluePolarity>no</cluePolarity> <clueManner>significant</clueManner> <clueType>effect</clueType> <linkTheme>on</linkTheme> the insulin-dependent and -independent PI 3-kinase activation.</clue>
</event>
<sentence id="S9">These results indicate that the mechanism by which <term id="T53" lex="YM268" sem="Organic_compound_other">YM268</term> increased <term id="T54" lex="glucose_uptake" sem="Other"><term id="A9" sem="Carbohydrate">glucose</term> uptake</term>, may be accounted for in part by the enhancement of <term id="T55" lex="GLUT1" sem="Protein_complex">GLUT1</term> and <term id="T56" lex="GLUT4" sem="Protein_complex">GLUT4</term> expression through <term id="T57" lex="PPARgamma_activation" sem="Other"><term id="T58" lex="PPARgamma" sem="Protein_molecule">PPARgamma</term> activation</term>.</sentence>
<event KT="Other" id="E44">
<type class="Localization"/>
<theme idref="A9"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose <clueType>uptake</clueType>, may be accounted for in part by the enhancement of GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
<event KT="Other" id="E45">
<type class="Positive_regulation"/>
<theme idref="E44"/>
<cause idref="T53"/>
<clue>These results indicate that the mechanism by which YM268 <clueType>increased</clueType> glucose uptake, may be accounted for in part by the enhancement of GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
<event KT="Other" id="E46">
<type class="Positive_regulation"/>
<theme idref="T58"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose uptake, may be accounted for in part by the enhancement of GLUT1 and GLUT4 expression through PPARgamma <clueType>activation</clueType>.</clue>
</event>
<event KT="Other" id="E47">
<type class="Gene_expression"/>
<theme idref="T55"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose uptake, may be accounted for in part by the enhancement of GLUT1 and GLUT4 <clueType>expression</clueType> through PPARgamma activation.</clue>
</event>
<event KT="Other" id="E48">
<type class="Gene_expression"/>
<theme idref="T56"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose uptake, may be accounted for in part by the enhancement of GLUT1 and GLUT4 <clueType>expression</clueType> through PPARgamma activation.</clue>
</event>
<event KT="Other" id="E49">
<type class="Positive_regulation"/>
<theme idref="E47"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose uptake, may be accounted for in part by the <clueType>enhancement</clueType> <linkTheme>of</linkTheme> GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
<event KT="Other" id="E50">
<type class="Positive_regulation"/>
<theme idref="E48"/>
<clue>These results indicate that the mechanism by which YM268 increased glucose uptake, may be accounted for in part by the <clueType>enhancement</clueType> <linkTheme>of</linkTheme> GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
<event CL="L1" KT="Analysis" id="E51" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="E49"/>
<clue>These results <clueKT>indicate</clueKT> that the mechanism by which YM268 increased glucose uptake, <clueCL>may</clueCL> be <clueType><clueKT>accounted</clueKT></clueType> for in part <linkCause>by</linkCause> the enhancement of GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
<event CL="L1" KT="Analysis" id="E52" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E45"/>
<cause idref="E50"/>
<clue>These results <clueKT>indicate</clueKT> that the mechanism by which YM268 increased glucose uptake, <clueCL>may</clueCL> be <clueType><clueKT>accounted</clueKT></clueType> for in part <linkCause>by</linkCause> the enhancement of GLUT1 and GLUT4 expression through PPARgamma activation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
